Korean J Androl.  2008 Dec;26(4):237-239.

Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate

Affiliations
  • 1Department of Urology, Korea University College of Medicine, Seoul, Korea. dgmoon@korea.ac.kr

Abstract

Polycythemia is a condition in which the red blood cell count is increased due to an inherited or acquired mutation, a physiologic response to hypoxia, autonomous erythropoietin production, or deliberate erythropoietin administration. Higher testosterone levels appear to act as a stimulus for erythropoiesis and testosterone replacement therapies have rarely been reported as causes of polycythemia. We report here a case of a 51-year-old man with polycythemia that was caused by long-acting testosterone undecanoate (Nebido(R)).

Keyword

Erythrocytosis; Polycythemia; Testosterone

MeSH Terms

Anoxia
Erythrocyte Count
Erythropoiesis
Erythropoietin
Humans
Middle Aged
Polycythemia
Testosterone
Erythropoietin
Testosterone
Full Text Links
  • KJA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr